Syndax Pharmaceuticals, Inc. (SNDX)
19.57
-0.08
(-0.41%)
USD |
NASDAQ |
Aug 24, 16:00
19.70
+0.13
(+0.66%)
After-Hours: 20:00
Syndax Pharmaceuticals Price to Book Value : 115.55 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 115.55 |
| August 21, 2026 | 116.02 |
| August 20, 2026 | 116.61 |
| August 19, 2026 | 122.63 |
| August 18, 2026 | 117.58 |
| August 17, 2026 | 116.67 |
| August 14, 2026 | 117.14 |
| August 13, 2026 | 112.65 |
| August 12, 2026 | 116.90 |
| August 11, 2026 | 119.80 |
| August 10, 2026 | 120.27 |
| August 07, 2026 | 120.45 |
| August 06, 2026 | 116.67 |
| August 05, 2026 | 117.61 |
| August 04, 2026 | 112.65 |
| August 03, 2026 | 113.60 |
| July 31, 2026 | 112.48 |
| July 30, 2026 | 115.01 |
| July 29, 2026 | 113.48 |
| July 28, 2026 | 115.90 |
| July 27, 2026 | 121.16 |
| July 24, 2026 | 122.87 |
| July 23, 2026 | 125.23 |
| July 22, 2026 | 130.19 |
| July 21, 2026 | 133.67 |
| Date | Value |
|---|---|
| July 20, 2026 | 131.61 |
| July 17, 2026 | 134.62 |
| July 16, 2026 | 134.09 |
| July 15, 2026 | 138.87 |
| July 14, 2026 | 142.47 |
| July 13, 2026 | 135.15 |
| July 10, 2026 | 139.40 |
| July 09, 2026 | 146.66 |
| July 08, 2026 | 145.01 |
| July 07, 2026 | 137.21 |
| July 06, 2026 | 130.37 |
| July 02, 2026 | 128.83 |
| July 01, 2026 | 123.34 |
| June 30, 2026 | 129.07 |
| June 29, 2026 | 46.33 |
| June 26, 2026 | 45.33 |
| June 25, 2026 | 42.14 |
| June 24, 2026 | 42.50 |
| June 23, 2026 | 41.72 |
| June 22, 2026 | 41.10 |
| June 18, 2026 | 40.42 |
| June 17, 2026 | 40.50 |
| June 16, 2026 | 39.46 |
| June 15, 2026 | 39.31 |
| June 12, 2026 | 38.82 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viking Therapeutics, Inc. | 9.494 |
| Kura Oncology, Inc. | 22.78 |
| ACADIA Pharmaceuticals, Inc. | 3.906 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Anika Therapeutics, Inc. | 2.080 |
Price to Book Value Related Metrics
| PS Ratio | 6.812 |
| Price | 19.57 |
| Earnings Yield | -12.87% |
| Market Cap | 1.745B |